Question 1

What is Alkermes?

Accepted Answer

Alkermes is a Company.

Question 2

How often does Alkermes appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was Alkermes first tracked by Ergen?

Accepted Answer

First tracked on Jun 15, 2026.

Question 4

When was Alkermes last mentioned in news?

Accepted Answer

Last active on Jul 28, 2026.

Question 5

What is Alkermes's current news sentiment?

Accepted Answer

Aggregate sentiment score: 38 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Alkermes in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Alkermes?

Accepted Answer

Alkermes' Alixorexton Gets Orphan Designations (Jun 15, 2026, 7 articles).

Question 8

How did the "Alkermes' Alixorexton Gets Orphan Designations" event impact Alkermes?

Accepted Answer

Alkermes received Orphan Drug Designations for alixorexton, which provides incentives and market exclusivity, positively impacting its drug development and potential future revenue.

Question 9

How did the "Alkermes Q2 2026 Earnings Release" event impact Alkermes?

Accepted Answer

Alkermes reported its Q2 2026 financial results and hosted a conference call. The event is central to the company's quarterly reporting cycle.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.